CAS 115104-28-4
:Acide 3-[[[3-[(1E)-2-(7-chloro-2-quinolinyl)éthényl]phényl][[3-(diméthylamino)-3-oxopropyl]thio]méthyl]thio]propanoïque
- 3-[({3-[(E)-2-(7-chloroquinolin-2-yl)ethenyl]phenyl}{[3-(dimethylamino)-3-oxopropyl]sulfanyl}methyl)sulfanyl]propanoic acid
- 3-[[[3-[(1E)-2-(7-Chloro-2-quinolinyl)ethenyl]phenyl][[3-(dimethylamino)-3-oxopropyl]thio]methyl]thio]propanoic Acid Sodium Salt
- 3-[[[3-[(1E)-2-(7-Chloro-2-quinolinyl)ethenyl]phenyl][[3-(dimethylamino)-3-oxopropyl]thio]methyl]thio]propanoic acid
- 3-{[(R)-{3-[(E)-2-(7-chloroquinolin-2-yl)ethenyl]phenyl}{[3-(dimethylamino)-3-oxopropyl]sulfanyl}methyl]sulfanyl}propanoic acid
- L 660711
- L 660711, Sodium Salt
- Mk-571
- Mk-571 Na
- Mk-571 Sodium Salt
- Mk-571, Na Salt
- Propanoic acid, 3-[[[3-[(1E)-2-(7-chloro-2-quinolinyl)ethenyl]phenyl][[3-(dimethylamino)-3-oxopropyl]thio]methyl]thio]-
- Propanoic acid, 3-[[[3-[2-(7-chloro-2-quinolinyl)ethenyl]phenyl][[3-(dimethylamino)-3-oxopropyl]thio]methyl]thio]-, (E)-
- Voir plus de synonymes
Propanoic acid, 3-[[[3-[(1E)-2-(7-chloro-2-quinolinyl)ethenyl]phenyl][[3-(dimethylamino)-3-oxopropyl]thio]methyl]thio]-
CAS :Formule :C26H27ClN2O3S2Degré de pureté :95%Couleur et forme :SolidMasse moléculaire :515.0872MK 571
CAS :MK 571 (L660711) is an orally active antagonist of CysLT1 receptor.Formule :C26H27ClN2O3S2Degré de pureté :98.69% - 99.65%Couleur et forme :SolidMasse moléculaire :515.09Ref: TM-T7841
2mg34,00€5mg50,00€10mg81,00€25mg165,00€50mg285,00€100mg432,00€200mg617,00€1mL*10mM (DMSO)59,00€MK-571
CAS :Produit contrôléStability Hygroscopic
Applications A receptor antagonist for the treatment of respiratory diseases. Cysteinyl leukotriene receptor antagonist MK-571 alters bronchoalveolar lavage fluid proteome in asthma.
References Morgenstern, R., et al.: Biochem. J., 260, 577 (1989), Armstrong, R., et al.: Chem. Res. Toxicol., 10, 2 (1997), Larsen, J., et al.: Ann. Allergy, 71, 103 (1993),Formule :C26H26ClN2O3S2·NaCouleur et forme :NeatMasse moléculaire :537.07MK 571
CAS :MK 571 is a drug that inhibits the ATP-binding cassette (ABC) transporter. MK 571 has been shown to inhibit leukotriene production in hl-60 cells and increase ATP release from myocardial infarcted hearts. It also inhibits the activity of nonsteroidal anti-inflammatory drugs and has been shown to have synergistic effects with other chemotherapeutic agents in cancer treatment.
Formule :C26H27ClN2O3S2Degré de pureté :Min. 95%Masse moléculaire :515.09 g/mol




